@article{f0f78d23c3bf4e75bac06f05c2438519,
title = "Bionanotechnologies for treatment and diagnosis of Alzheimer's disease",
author = "Moghimi, {S. Moein}",
note = "Funding Information: To this end, a pan-European effort comprising 19 research centers located in 13 European Union countries (Belgium, Denmark, Finland, France, Greece, Hungary, Italy, the Netherlands, Portugal, Slovakia, Spain, Sweden, and the United Kingdom), and supported by the European Commission Seventh Framework Programme, have started an ambitious and a challenging approach to combat AD. 3 The project, Nanoparticles for Therapy and Diagnosis of Alzheimer's Disease ( http://www.nadproject.eu/ ) began in September 2008 for a duration of 5 years and with a total budget of 14 million Euros. The NAD project is interdisciplinary in nature and integrates bionanotechnology initiatives and approaches to treat AD. It is the intention of this Special Issue of Nanomedicine: NBM to celebrate some of the findings and developments reported by this consortium during the EuroNanoForum 2011 in Budapest, Hungary (1-3 June 2011). ",
year = "2011",
month = oct,
doi = "10.1016/j.nano.2011.05.001",
language = "English (US)",
volume = "7",
pages = "515--518",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier",
number = "5",
}